Mississippi Senate passes medical marijuana bill; House vote is next

Did you miss the webinar “Women Leaders in Cannabis: Shattering the Grass Ceiling?” Head to MJBiz YouTube to watch it now!


The Mississippi state Senate on Thursday passed a medical marijuana law, sending it to the House of Representatives, where approval is less certain.

The legislative action came more than a year after voters soundly approved a legalization initiative at the ballot box, only to see the state Supreme Court void the measure on a technical issue.

Senate Bill 2095, the Mississippi Medical Cannabis Act of 2022, is more restrictive than the business-friendly Initiative 65 passed by voters.

One major difference is that the legislation would allow municipalities to opt out of the industry.

House Speaker Philip Gunn has said legalization “is not a top issue for us,” according to Mississippi Today.

But Republican Rep. Lee Yancey, who is spearheading the effort in the House, expressed optimism to the newspaper about its chances of passage.

It’s also unclear whether the current version would be acceptable to Republican Gov. Tate Reeves.

Reeves wouldn’t call a special legislative session last year to pass a measure and most recently expressed concerns about the amount of marijuana that would be allowed to be purchased by MMJ patients.

Stay informed with MJBiz Newsletters

MJBiz’s family of newsletters gives cannabis professionals an edge in this rapidly changing industry.

Featured newsletters:
  • MJBizDaily: Business news for cannabis leaders in your inbox each morning
  • MJBiz Cultivator: Insights for wholesale cannabis growers & vertically integrated businesses
  • MJBizCon Buzz: Behind-the-scenes buzz on everything MJBizCon
  • MJBiz Retail + Brand: New products, trends and news for cannabis retailers, distributors and marketers
  • Hemp Industry Week: Roundup of news from hemp farming to CBD product manufacturing
  • And more!

 

Here are some key business elements to the proposed bill, according to Mississippi Today:

  • Patients could purchase up to 3.5 ounces of marijuana a month. That’s slightly lower than the 5 ounces a month in the 2020 referendum.
  • Cultivation would be indoor only. There would be six cultivation tiers, ranging from a micro-cultivator capped at 1,000 square feet to a tier 6 grower of 100,000 square feet or more.
  • Roughly 25 patient conditions would qualify, including all 22 that were in Initiative 65.
  • A seed-to-sale tracking system would be created, and the proposed law calls for criminal penalties for violations.
  • A 5% excise tax would be imposed for cultivation in addition to the state sales tax (currently 7%) for retail sales.